ENTRY       hsa00020                    Pathway
NAME        Citrate cycle (TCA cycle) - Homo sapiens (human)
DESCRIPTION The citrate cycle (TCA cycle, Krebs cycle) is an important aerobic pathway for the final steps of the oxidation of carbohydrates and fatty acids. The cycle starts with acetyl-CoA, the activated form of acetate, derived from glycolysis and pyruvate oxidation for carbohydrates and from beta oxidation of fatty acids. The two-carbon acetyl group in acetyl-CoA is transferred to the four-carbon compound of oxaloacetate to form the six-carbon compound of citrate. In a series of reactions two carbons in citrate are oxidized to CO2 and the reaction pathway supplies NADH for use in the oxidative phosphorylation and other metabolic processes. The pathway also supplies important precursor metabolites including 2-oxoglutarate. At the end of the cycle the remaining four-carbon part is transformed back to oxaloacetate. According to the genome sequence data, many organisms seem to lack genes for the full cycle [MD:M00009], but contain genes for specific segments [MD:M00010 M00011].
CLASS       Metabolism; Carbohydrate metabolism
PATHWAY_MAP hsa00020  Citrate cycle (TCA cycle)
MODULE      hsa_M00003  Gluconeogenesis, oxaloacetate => fructose-6P [PATH:hsa00020]
            hsa_M00009  Citrate cycle (TCA cycle, Krebs cycle) [PATH:hsa00020]
            hsa_M00010  Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate [PATH:hsa00020]
            hsa_M00011  Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate [PATH:hsa00020]
            hsa_M00307  Pyruvate oxidation, pyruvate => acetyl-CoA [PATH:hsa00020]
DISEASE     H00073  Pyruvate carboxylase deficiency
            H00469  Mitochondrial DNA depletion syndrome (MDS)
            H00804  Multiple cutaneous and uterine leiomyomata
            H01022  Diseases of the tricarboxylic acid cycle
            H01222  Cowden-like syndrome
            H01225  D-2-hydroxyglutaric aciduria (D-2-HGA)
DRUG        D10691  Bempedoic acid (USAN/INN)
DBLINKS     BSID: 82927
            GO: 0006099
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        1431  CS; citrate synthase [KO:K01647] [EC:2.3.3.1]
            47  ACLY; ATP citrate lyase [KO:K01648] [EC:2.3.3.8]
            50  ACO2; aconitase 2 [KO:K01681] [EC:4.2.1.3]
            48  ACO1; aconitase 1 [KO:K01681] [EC:4.2.1.3]
            3417  IDH1; isocitrate dehydrogenase 1 (NADP+) [KO:K00031] [EC:1.1.1.42]
            3418  IDH2; isocitrate dehydrogenase 2 (NADP+), mitochondrial [KO:K00031] [EC:1.1.1.42]
            3420  IDH3B; isocitrate dehydrogenase 3 (NAD+) beta [KO:K00030] [EC:1.1.1.41]
            3421  IDH3G; isocitrate dehydrogenase 3 (NAD+) gamma [KO:K00030] [EC:1.1.1.41]
            3419  IDH3A; isocitrate dehydrogenase 3 (NAD+) alpha [KO:K00030] [EC:1.1.1.41]
            55753  OGDHL; oxoglutarate dehydrogenase-like [KO:K00164] [EC:1.2.4.2]
            4967  OGDH; oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) [KO:K00164] [EC:1.2.4.2]
            1743  DLST; dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) [KO:K00658] [EC:2.3.1.61]
            1738  DLD; dihydrolipoamide dehydrogenase [KO:K00382] [EC:1.8.1.4]
            8802  SUCLG1; succinate-CoA ligase, alpha subunit [KO:K01899] [EC:6.2.1.5 6.2.1.4]
            8801  SUCLG2; succinate-CoA ligase, GDP-forming, beta subunit [KO:K01900] [EC:6.2.1.5 6.2.1.4]
            8803  SUCLA2; succinate-CoA ligase, ADP-forming, beta subunit [KO:K01900] [EC:6.2.1.5 6.2.1.4]
            6389  SDHA; succinate dehydrogenase complex subunit A, flavoprotein (Fp) [KO:K00234] [EC:1.3.5.1]
            6390  SDHB; succinate dehydrogenase complex subunit B, iron sulfur (Ip) [KO:K00235] [EC:1.3.5.1]
            6391  SDHC; succinate dehydrogenase complex subunit C [KO:K00236]
            6392  SDHD; succinate dehydrogenase complex subunit D, integral membrane protein [KO:K00237]
            2271  FH; fumarate hydratase [KO:K01679] [EC:4.2.1.2]
            4190  MDH1; malate dehydrogenase 1 [KO:K00025] [EC:1.1.1.37]
            4191  MDH2; malate dehydrogenase 2 [KO:K00026] [EC:1.1.1.37]
            5091  PC; pyruvate carboxylase [KO:K01958] [EC:6.4.1.1]
            5105  PCK1; phosphoenolpyruvate carboxykinase 1 [KO:K01596] [EC:4.1.1.32]
            5106  PCK2; phosphoenolpyruvate carboxykinase 2 (mitochondrial) [KO:K01596] [EC:4.1.1.32]
            5161  PDHA2; pyruvate dehydrogenase (lipoamide) alpha 2 [KO:K00161] [EC:1.2.4.1]
            5160  PDHA1; pyruvate dehydrogenase (lipoamide) alpha 1 [KO:K00161] [EC:1.2.4.1]
            5162  PDHB; pyruvate dehydrogenase (lipoamide) beta [KO:K00162] [EC:1.2.4.1]
            1737  DLAT; dihydrolipoamide S-acetyltransferase [KO:K00627] [EC:2.3.1.12]
COMPOUND    C00022  Pyruvate
            C00024  Acetyl-CoA
            C00026  2-Oxoglutarate
            C00036  Oxaloacetate
            C00042  Succinate
            C00068  Thiamin diphosphate
            C00074  Phosphoenolpyruvate
            C00091  Succinyl-CoA
            C00122  Fumarate
            C00149  (S)-Malate
            C00158  Citrate
            C00311  Isocitrate
            C00417  cis-Aconitate
            C05125  2-(alpha-Hydroxyethyl)thiamine diphosphate
            C05379  Oxalosuccinate
            C05381  3-Carboxy-1-hydroxypropyl-ThPP
            C15972  Enzyme N6-(lipoyl)lysine
            C15973  Enzyme N6-(dihydrolipoyl)lysine
            C16254  [Dihydrolipoyllysine-residue succinyltransferase] S-succinyldihydrolipoyllysine
            C16255  [Dihydrolipoyllysine-residue acetyltransferase] S-acetyldihydrolipoyllysine
REFERENCE   (map 2)
  AUTHORS   Nishizuka Y (ed).
  TITLE     [Metabolic Maps] (In Japanese)
  JOURNAL   Tokyo Kagaku Dojin (1980)
REFERENCE   (map 3)
  AUTHORS   Nishizuka Y, Seyama Y, Ikai A, Ishimura Y, Kawaguchi A (eds).
  TITLE     [Cellular Functions and Metabolic Maps] (In Japanese)
  JOURNAL   Tokyo Kagaku Dojin (1997)
REFERENCE   
  AUTHORS   Michal G.
  TITLE     Biochemical Pathways
  JOURNAL   Wiley (1999)
KO_PATHWAY  ko00020
///
